Foresite Capital
company
Investments
Number of Investments
Number of Lead Investments
31
8
Foresite Capital has made 31 investments. Their most recent investment was on
Mar 8, 2022, when DNAnexus, Inc raised
| Date | Company Name | Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|---|
| Mar 8, 2022 | DNAnexus | Series H | — | Bioinformatics | — |
| Jan 6, 2022 | Eikon Therapeutics | Series B | — | Biotechnology | — |
| Sep 9, 2021 | Mammoth Biosciences | Series D | — | Biotechnology | — |
| Jun 29, 2021 | Element Biosciences | Series C | — | Biotechnology | — |
| Jun 28, 2021 | HealthVerity | Series D | — | Health Care | — |
| May 11, 2021 | Aetion | Series C | — | Analytics | — |
| May 5, 2021 | Eikon Therapeutics | Series A | — | Biotechnology | — |
| Nov 25, 2020 | SomaLogic | Series A | — | Biotechnology | — |
| Nov 4, 2020 | Mammoth Biosciences | Series C | — | Biotechnology | Yes |
| Jun 10, 2020 | Cue | Series C | — | Health Care | — |
| Jun 9, 2020 | DNAnexus | Series G | — | Bioinformatics | — |
| Jan 11, 2020 | PACT Pharma | Series C | — | Biotechnology | — |
| Jan 9, 2020 | Element Biosciences | Series B | — | Biotechnology | — |
| Nov 21, 2019 | Genapsys | Series C | — | Bioinformatics | Yes |
| Aug 9, 2019 | ORIC Pharmaceuticals | Series D | — | Biotechnology | — |
| Jun 18, 2019 | Element Biosciences | Series A | — | Biotechnology | Yes |
| Apr 3, 2019 | HealthVerity | Series C | — | Health Care | Yes |
| Feb 6, 2019 | DNAnexus | Series F | — | Bioinformatics | — |
| Feb 21, 2018 | ORIC Pharmaceuticals | Series C | — | Biotechnology | — |
| Jan 2, 2018 | DNAnexus | Series E | — | Bioinformatics | Yes |
| Nov 13, 2017 | Arcus Biosciences | Series C | — | Biotechnology | — |
| Sep 8, 2017 | Replimune Group | Series B | — | Biotechnology | Yes |
| Sep 1, 2016 | Arcus Biosciences | Series B | — | Biotechnology | — |
| Feb 17, 2016 | 10X Genomics | Series C | — | Biotechnology | — |
| Jan 19, 2016 | Twist Bioscience | Series D | — | Biotechnology | — |
| Dec 2, 2015 | ORIC Pharmaceuticals | Series B | — | Biotechnology | — |
| Sep 1, 2015 | Intellia Therapeutics | Series B | — | Biotechnology | — |
| Jun 22, 2015 | Ardelyx | Post-IPO Equity | — | Biotechnology | — |
| Jun 9, 2015 | Twist Bioscience | Series C | — | Biotechnology | — |
| Dec 12, 2014 | 10X Genomics | Series B | — | Biotechnology | Yes |
| Jul 31, 2013 | Karyopharm Therapeutics | Series B | — | Health Care | Yes |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
